2-dibenzofuran-4-yl-4-(3-dibenzofuran-4-yl-2,5-diphenylphenyl)-6-phenyl-1,3,5-triazine
C51H31N3O2 — CID 177079173
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-dibenzofuran-4-yl-4-(3-dibenzofuran-4-yl-2,5-diphenylphenyl)-6-phenyl-1,3,5-triazine
2-dibenzofuran-4-yl-4-(3-dibenzofuran-4-yl-2,5-diphenylphenyl)-6-phenyl-1,3,5-triazine (PubChem CID 177079173) has the molecular formula C51H31N3O2 and a molecular weight of 717.83 g/mol. Its IUPAC name is 2-dibenzofuran-4-yl-4-(3-dibenzofuran-4-yl-2,5-diphenylphenyl)-6-phenyl-1,3,5-triazine.
Molecular Properties
| Compound Name | 2-dibenzofuran-4-yl-4-(3-dibenzofuran-4-yl-2,5-diphenylphenyl)-6-phenyl-1,3,5-triazine |
|---|---|
| PubChem CID | 177079173 |
| Molecular Formula | C51H31N3O2 |
| Molecular Weight | 717.83 g/mol |
| Exact Mass | 717.24 |
| IUPAC Name | 2-dibenzofuran-4-yl-4-(3-dibenzofuran-4-yl-2,5-diphenylphenyl)-6-phenyl-1,3,5-triazine |
| SMILES | c1ccc(-c2cc(-c3nc(-c4ccccc4)nc(-c4cccc5c4oc4ccccc45)n3)c(-c3ccccc3)c(-c3cccc4c3oc3ccccc34)c2)cc1 |
| InChI | InChI=1S/C51H31N3O2/c1-4-16-32(17-5-1)35-30-42(40-26-14-24-38-36-22-10-12-28-44(36)55-47(38)40)46(33-18-6-2-7-19-33)43(31-35)51-53-49(34-20-8-3-9-21-34)52-50(54-51)41-27-15-25-39-37-23-11-13-29-45(37)56-48(39)41/h1-31H |
| InChIKey | SPLVBVJCRCKCIZ-UHFFFAOYSA-N |
| XLogP | 13.67 |
| TPSA | 64.95 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 56 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 717.83 |
| LogP ≤ 5 | 13.67 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177079173 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.